Combined linkage and association studies show that HLA class II variants control levels of antibodies against Epstein-Barr virus antigens.

Over 95% of the adult population worldwide is infected with Epstein-Barr virus (EBV). EBV infection is associated with the development of several cancers, including Hodgkin lymphoma (HL). Elevated levels of anti-EBV antibodies have been associated with increased risk of HL. There is growing evidence...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vincent Pedergnana, Laurène Syx, Aurélie Cobat, Julien Guergnon, Pauline Brice, Christophe Fermé, Patrice Carde, Olivier Hermine, Catherine Le-Pendeven, Corinne Amiel, Yassine Taoufik, Alexandre Alcaïs, Ioannis Theodorou, Caroline Besson, Laurent Abel
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d519758268c44a409713dc620f94975a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d519758268c44a409713dc620f94975a
record_format dspace
spelling oai:doaj.org-article:d519758268c44a409713dc620f94975a2021-11-25T06:08:28ZCombined linkage and association studies show that HLA class II variants control levels of antibodies against Epstein-Barr virus antigens.1932-620310.1371/journal.pone.0102501https://doaj.org/article/d519758268c44a409713dc620f94975a2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25025336/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Over 95% of the adult population worldwide is infected with Epstein-Barr virus (EBV). EBV infection is associated with the development of several cancers, including Hodgkin lymphoma (HL). Elevated levels of anti-EBV antibodies have been associated with increased risk of HL. There is growing evidence that genetic factors control the levels of antibodies against EBV antigens. Here, we conducted linkage and association studies to search for genetic factors influencing either anti-viral capsid antigen (VCA) or anti-Epstein Barr nuclear antigen-1 (EBNA-1) IgG levels in a unique cohort of 424 individuals of European origin from 119 French families recruited through a Hodgkin lymphoma (HL) patient. No major locus controlling anti-VCA antibody levels was identified. However, we found that the HLA region influenced anti-EBNA-1 IgG titers. Refined association studies in this region identified a cluster of HLA class II variants associated with anti-EBNA-1 IgG titers (e.g. p = 5×10(-5) for rs9268403). The major allele of rs9268403 conferring a predisposition to high anti-EBNA-1 antibody levels was also associated with an increased risk of HL (p = 0.02). In summary, this study shows that HLA class II variants influenced anti-EBNA-1 IgG titers in a European population. It further shows the role of the same variants in the risk of HL.Vincent PedergnanaLaurène SyxAurélie CobatJulien GuergnonPauline BriceChristophe FerméPatrice CardeOlivier HermineCatherine Le-PendevenCorinne AmielYassine TaoufikAlexandre AlcaïsIoannis TheodorouCaroline BessonLaurent AbelPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 7, p e102501 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Vincent Pedergnana
Laurène Syx
Aurélie Cobat
Julien Guergnon
Pauline Brice
Christophe Fermé
Patrice Carde
Olivier Hermine
Catherine Le-Pendeven
Corinne Amiel
Yassine Taoufik
Alexandre Alcaïs
Ioannis Theodorou
Caroline Besson
Laurent Abel
Combined linkage and association studies show that HLA class II variants control levels of antibodies against Epstein-Barr virus antigens.
description Over 95% of the adult population worldwide is infected with Epstein-Barr virus (EBV). EBV infection is associated with the development of several cancers, including Hodgkin lymphoma (HL). Elevated levels of anti-EBV antibodies have been associated with increased risk of HL. There is growing evidence that genetic factors control the levels of antibodies against EBV antigens. Here, we conducted linkage and association studies to search for genetic factors influencing either anti-viral capsid antigen (VCA) or anti-Epstein Barr nuclear antigen-1 (EBNA-1) IgG levels in a unique cohort of 424 individuals of European origin from 119 French families recruited through a Hodgkin lymphoma (HL) patient. No major locus controlling anti-VCA antibody levels was identified. However, we found that the HLA region influenced anti-EBNA-1 IgG titers. Refined association studies in this region identified a cluster of HLA class II variants associated with anti-EBNA-1 IgG titers (e.g. p = 5×10(-5) for rs9268403). The major allele of rs9268403 conferring a predisposition to high anti-EBNA-1 antibody levels was also associated with an increased risk of HL (p = 0.02). In summary, this study shows that HLA class II variants influenced anti-EBNA-1 IgG titers in a European population. It further shows the role of the same variants in the risk of HL.
format article
author Vincent Pedergnana
Laurène Syx
Aurélie Cobat
Julien Guergnon
Pauline Brice
Christophe Fermé
Patrice Carde
Olivier Hermine
Catherine Le-Pendeven
Corinne Amiel
Yassine Taoufik
Alexandre Alcaïs
Ioannis Theodorou
Caroline Besson
Laurent Abel
author_facet Vincent Pedergnana
Laurène Syx
Aurélie Cobat
Julien Guergnon
Pauline Brice
Christophe Fermé
Patrice Carde
Olivier Hermine
Catherine Le-Pendeven
Corinne Amiel
Yassine Taoufik
Alexandre Alcaïs
Ioannis Theodorou
Caroline Besson
Laurent Abel
author_sort Vincent Pedergnana
title Combined linkage and association studies show that HLA class II variants control levels of antibodies against Epstein-Barr virus antigens.
title_short Combined linkage and association studies show that HLA class II variants control levels of antibodies against Epstein-Barr virus antigens.
title_full Combined linkage and association studies show that HLA class II variants control levels of antibodies against Epstein-Barr virus antigens.
title_fullStr Combined linkage and association studies show that HLA class II variants control levels of antibodies against Epstein-Barr virus antigens.
title_full_unstemmed Combined linkage and association studies show that HLA class II variants control levels of antibodies against Epstein-Barr virus antigens.
title_sort combined linkage and association studies show that hla class ii variants control levels of antibodies against epstein-barr virus antigens.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/d519758268c44a409713dc620f94975a
work_keys_str_mv AT vincentpedergnana combinedlinkageandassociationstudiesshowthathlaclassiivariantscontrollevelsofantibodiesagainstepsteinbarrvirusantigens
AT laurenesyx combinedlinkageandassociationstudiesshowthathlaclassiivariantscontrollevelsofantibodiesagainstepsteinbarrvirusantigens
AT aureliecobat combinedlinkageandassociationstudiesshowthathlaclassiivariantscontrollevelsofantibodiesagainstepsteinbarrvirusantigens
AT julienguergnon combinedlinkageandassociationstudiesshowthathlaclassiivariantscontrollevelsofantibodiesagainstepsteinbarrvirusantigens
AT paulinebrice combinedlinkageandassociationstudiesshowthathlaclassiivariantscontrollevelsofantibodiesagainstepsteinbarrvirusantigens
AT christopheferme combinedlinkageandassociationstudiesshowthathlaclassiivariantscontrollevelsofantibodiesagainstepsteinbarrvirusantigens
AT patricecarde combinedlinkageandassociationstudiesshowthathlaclassiivariantscontrollevelsofantibodiesagainstepsteinbarrvirusantigens
AT olivierhermine combinedlinkageandassociationstudiesshowthathlaclassiivariantscontrollevelsofantibodiesagainstepsteinbarrvirusantigens
AT catherinelependeven combinedlinkageandassociationstudiesshowthathlaclassiivariantscontrollevelsofantibodiesagainstepsteinbarrvirusantigens
AT corinneamiel combinedlinkageandassociationstudiesshowthathlaclassiivariantscontrollevelsofantibodiesagainstepsteinbarrvirusantigens
AT yassinetaoufik combinedlinkageandassociationstudiesshowthathlaclassiivariantscontrollevelsofantibodiesagainstepsteinbarrvirusantigens
AT alexandrealcais combinedlinkageandassociationstudiesshowthathlaclassiivariantscontrollevelsofantibodiesagainstepsteinbarrvirusantigens
AT ioannistheodorou combinedlinkageandassociationstudiesshowthathlaclassiivariantscontrollevelsofantibodiesagainstepsteinbarrvirusantigens
AT carolinebesson combinedlinkageandassociationstudiesshowthathlaclassiivariantscontrollevelsofantibodiesagainstepsteinbarrvirusantigens
AT laurentabel combinedlinkageandassociationstudiesshowthathlaclassiivariantscontrollevelsofantibodiesagainstepsteinbarrvirusantigens
_version_ 1718414132338753536